MedPath

Prediction of the effect of chemotherapy and prognosis based on gene and metabolome analysis by specimen collected by EUSFNA on pancreatic cancer

Not Applicable
Recruiting
Conditions
pancreatic cancer
Registration Number
JPRN-UMIN000026261
Lead Sponsor
Division of Gastroenterology, Department of Internal medicine, Kobe University Graduate School of Medicine
Brief Summary

To find the relationship between prognosis/ sensitivity of chemotherapy and molecular characteristics of pancreatic cancer or metabolic profile of pancreatic cancer

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
250
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relation between frequency of genetic mutation and effect of chemotherapy
Secondary Outcome Measures
NameTimeMethod
Relation between metabolite and effect of chemotherapy Relation between frequency of genetic mutation and metabolite of tissue and blood
© Copyright 2025. All Rights Reserved by MedPath